MedinCell
FranceEntry
2017
Hold
9yr
Status
Active
Who owns MedinCell?
MedinCell is a French Pharma company, currently owned by Crédit Mutuel Equity since 2017 and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Seventure PartnersHealth for Life Capital · 2014 · VC
3 ownership periods · full history below
Key facts
HQFrance
SectorPharma
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2017 · present
Crédit Mutuel EquityActive
2017 · present(9yr) · Crédit Mutuel Equity · 1992 · Growth
Seventure PartnersActive
2017 · present(9yr) · Health for Life Capital · 2014 · VC
Crédit Mutuel InnovationActive
2017 · present(9yr) · Crédit Mutuel Innovation Evergreen Capital · 2004 · Evergreen
More from Health for Life Capital
Other portfolio companies in the same fund.
UK
BelgiumMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns MedinCell?
MedinCell is currently owned by Crédit Mutuel Equity, Crédit Mutuel Innovation and 1 other, through Health for Life Capital, since 2017.
When did Crédit Mutuel Equity and 2 others acquire MedinCell?
Crédit Mutuel Equity and 2 others acquired MedinCell in 2017.
Who has owned MedinCell over time?
MedinCell has been through 3 private-equity ownership periods: Crédit Mutuel Equity · via Crédit Mutuel Equity · since 2017; Crédit Mutuel Innovation · via Crédit Mutuel Innovation Evergreen Capital · since 2017; Seventure Partners · via Health for Life Capital · since 2017.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue